P-Glycoprotein and outcome following heart transplantation. J.B. Barnard, J.E.Fildes, S.J.Richardson, C.T.Leonard, V..P.Pravicia, Ian V. Hutchinson, Nizar Yonan. 12th Congress of the European Society for Organ Transplantation, October 2005, Geneva, Switzerland.
Orthotopic heart transplantation for rare indication: A single centre experience. R.Sivaprakasam, A.Machaal, N.Yonan. 12th Congress of the European Society for Organ Transplantation, October 2005, Geneva, Switzerland.
Donor lung selection: Wythenshawe Experience. N.Khasati, J.B.Barnard, A.Machaal, C.T.Leonard, NYonan. 12th Congress of the European Society for Organ Transplantation, October 2005, Geneva, Switzerland.
Pharmacokinetic profiling and C2 monitoring of Cyclosporine improves outcome following heart transplantation. J.Barnard, M.N.Bittar, S.Richardson, R.Martyszczuck, J.E.Fildes, N.Khasati, B.Keevil, N.Yonan. 12th Congress of the European Society for Organ Transplantation, October 2005, Geneva, Switzerland.
Orthotopic heart transplantation for patients at risk of sepsis: A 15 years experience. R.Sivaprakasam, N.Khasati, A.Machaal, N.Yonan. 12th Congress of the European Society for Organ Transplantation, October 2005, Geneva, Switzerland.
Polymorphism of the multidrug resistance gene is associated with increased incidence of heart transplant rejection. J.B.Barnard, S.J.Richardson, N.Khasati, J.E.Fildes, M.N.Bittar, V.Pravicia, I.V.Hutchinson, N.Yonan. 12th Congress of the European Society for Organ Transplantation, October 2005, Geneva, Switzerland.
P-Glycoprotein expression following administration of Cyclosporine. J.Thekkudan, J.Fildes, R.Guntamadugu, N.Yonan, C.Leonard. 12th Congress of the European Society for Organ Transplantation, October 2005, Geneva, Switzerland.
Diurnal variation in Cyclosporine levels. J.Thekkudan, R.Martyszczuk, A.Baynes, J.Fildes, S.Datta, C.Leonard, B.Keevil, N.Yonan. 12th Congress of the European Society for Organ Transplantation, October 2005, Geneva, Switzerland.
Incidence of infection in single lung transplant recipients. Comparison of Mycophenolate mefetil and Azathioprine. S.J.Richardson, J.R.Cain, J.B.Barnard, M.N.Bittar, N.Yonan, C.Leonard. 12th Congress of the European Society for Organ Transplantation, October 2005, Geneva, Switzerland.
Pulmonary vein gas as a tool for assessing donor lungs. J.Thekkudan, J.E.Fildes, S. Datta, A.A.Machaal, C.T.Leonard and N.Yonan. The International Society of Heart and Lung Transplantation, April 2005, Philadelphia, USA.
Self-administered fingerprick sampling to determine cyclosporine C2 blood levels in transplant patients. N.Yonan, R.Martyszczuk, A.Machaal, A.Baynes, J.Thekkudam and B.G.Keevil. The International Society of Heart and Lung Transplantation, April 2005, Philadelphia, USA.
Cyclosprine profiling in heart transplant patients: Correlation with clinical outcome. J.Barnard, J.Thekkudan, S.Richardson, R.Martyszczuck, M.Bittar, N.Khasati, B.Keevil and N.Yonan. The International Society of Heart and Lung Transplantation, April 2005, Philadelphia, USA.
Association of Vascular Endothelial Growth Factor gene polymorphism with acute rejection after lung and heart-lung transplantation. S.Datta, C.Leonard, N.Yonan and I.V.Hutchinson. The International Society of Heart and Lung Transplantation, April 2005, Philadelphia, USA.
The role of NKR-P1A following lung transplantation. J.E.Fildes, A.H.Walker, J.Thekkudan, K.Polster, N.Yonan, I.V.Hutchinson and C.T.Leonard. The International Society of Heart and Lung Transplantation, April 2005, Philadelphia, USA.
Peripheral blood natural killer cells and CMV activation following lung transplantation. J.E.Fildes, A.H.Walker, J.Thekkudan, K.Polster, M.Guiver, N.Yonan, I.V.Hutchinson and C.Leonard. The International Society of Heart and Lung Transplantation, April 2005, Philadelphia, USA.
Association of donor tumor necrosis factor-alpha gene-308 polymorphism with acute rejection after heart transplantation. S.Datta, C.Densum, N.Yonan and I.V.Hutchinson. The International Society of Heart and Lung Transplantation, April 2005, Philadelphia, USA.
The Donor CCR5 Delta32 Polymorphism and Outcome Following Cardiac Transplantation. J.E.Fildes, A.H.Walker, R.Howlett, I.V.Hutchinson, C.T.Leonard, and N.Yonan. The British Society of Immunology, December 2004. Harrogate, UK
The ACE I/D Polymorphism and Platelet Derived Growth Factor Level – A Genetic Link? A.H.Walker, J.E.Fildes, I.V.Hutchinson, C.T.Leonard, N.Yonan. The British Society of Immunology, December 2004. Harrogate, UK
Multi drug resistance pump (p-glycoprotein) expression in perepheral blood of heart transplant recipients is not associated with rejection. J. Thekkudan, J.E. Fildes, R. Guntamadugu, A. Owen, A.Walker, S. Datta, D. Singh, I.V.Hutchinson, N. Yonan, C Leonard. The 20th International Congress of Transplantation, September 2004, Vienna, Austria
The Effects of ACE Inhibition on Serum Angiotensin II Concentration Following Cardiac Transplantation. J.E.Fildes, A.H.Walker, B.Keevil, I.V.Hutchinson, C.T.Leonard, and N.Yonan. The 20th International Congress of Transplantation, September 2004, Vienna, Austria
Orthotropic heart transplantation for rare indications; A single centre experience. R. Sivaprakasam, R. Guntamadugu, N. Khasati, A. Machaal, N. Yonan. The 20th International Congress of Transplantation, September 2004, Vienna, Austria
Donor heart selection: Wythenshawe experience. N. Khasati, M.N Bittar, A. Machaal, R. Shah, T. Aziz, N. Yonan. The 20th International Congress of Transplantation, September 2004, Vienna, Austria
Association of Mycophenolate Mofetil with fibroblast growth factor expression in patients with obliterative bronchiolitis following clinical lung transplantation. S. Datta, C.L. Leonard, N. Yonan. The 20th International Congress of Transplantation, September 2004, Vienna, Austria
Association of vascular endothelial growth factor gene polymorphism with acute rejection and coronary artery disease after orthotopic heart transplantation. S.Datta, J.E.Fildes, C.T.Leonard, N.Yonan and I.V.Hutchinson. 3rd Joint Meeting of the European Association of Cardiothoracic Surgery and the European Society of Thoracic Surgeons, September 2004, Leipzig, Germany
Tumour Necrosis Factor Alpha (TNF-α) Gene Polymorphism A-308G Influences Inflammatory Response Following Coronary Revascularisation. M.N.Bittar, J.Carey, N.Khasati, A.Machaal, V.Pravica, I.V.Hutchinson, N.Yonan. The British Society of Cardiothoracic Surgery. Bristol, UK, July 2004
The Role of NKR-P1A in Lung Transplantation – A preliminary Report. J.E.Fildes, A.H.Walker, V.Pravica, N.Yonan, I.V.Hutchinson, C.T.Leonard. The Post Graduate Symposium. July 2004, Manchester, UK.
P-glycoprotein and outcome following lung transplantation. J E Fildes, J Thekkudan, R Guntamadugu, A Owen, D Singh, N Yonan and C T Leonard. The International Society of Heart and Lung Transplantation, April, 2004, San Francisco, USA.
Caveats of Cyclosporine dosing based on C2 monitoring. J Thekkudan, J E Fildes, R Sivaprakasam, N Khasati, S Datta, R Martyszczuck, A A Maachal, B Keevil, C T Leonard and N Yonan. The International Society of Heart and Lung Transplantation, April, 2004, San Francisco, USA.
The angiotensin converting enzyme insertion/deletion polymorphism does not influence the development or progression of post cardiac transplant hypertension. J E Fildes, A H Walker, C G Densem, A K Deiraniya, I V Hutchinson, C T Leonard and N Yonan. The International Society of Heart and Lung Transplantation, April, 2004, San Francisco, USA.
Vascular endothelial growth factor gene polymorphism are associated with allograft coronary artery disease after clinical heart transplantation. S.Datta, J.Fildes, J.Thekkuden, R.Sivaprakasam, N.Yonan, I.V.Hutchinson. The International Society of Heart and Lung Transplantation, April 2004, San Francisco, USA.
Risk/benefit evaluation of tacrolimus (TAC) vs. cyclosporine microemulsion (CsA) after cardiac transplantation: 18-month results. M.Rinaldi, M.Grimm, N.Yonan and the European Tacrolimus Heart Study Group. The International Society of Heart and Lung Transplantation, April 2004, San Francisco, USA.
Inhaled nitric oxide as rescue therapy for right ventricular insufficiency after orthotopic heart transplantation. S.Datta, A.Machaal, J.Thekkudan, R.Sivaprakasan, A.K.Deiraniya and N.Yonan. The International Society of Heart and Lung Transplantation, April 2004, San Francisco, USA.
Safety of sputum induction in lung transplant recipients. D.J.Allen, J.E.Fildes, N.Yonan, C.T.Leonard. The American Transplantation Society. March 2004, Orlando, USA.
Correlation between induced sputum neutrophil percentage and decline from best postoperative baseline in FEV1, FEF25-75 and FEF50. D.J. Allen, J.E. Fildes, N. Yonan, A.K. Deiraniya, C.T. Leonard. The International Society of Heart and Lung Transplantation, April 2003, Vienna, Austria.
Vascular endothelial growth factor gene polymorphism are associated with acute rejection after heart transplantation. S. Datta, J. Fildes, A.K. Deiraniya, N. Yonan, I.V. Hutchinson. The International Society of Heart and Lung Transplantation, April 2003, Vienna, Austria.
Efficacy and safety of tacrolimus (TAC) vs. cyclosporine microemulsion (CME) in de novo cardiac transplant recipients: 6-month results. M.Grimm, M.Rinaldi, N.Yonan and the European Tacrolimus Heart Study Group. The International Society of Heart and Lung Transplantation, April 2003, Vienna, Austria.
Cyclosporin 2-hr post dose monitoring-a potentially valuable tool for optimising immunosuppresssion after heart transplantation. S.Datta, J.Hassan, A.Machaal, R.Martyszczuk, A.K.Deiraniya and N.Yonan. The International Society of Heart and Lung Transplantation, April 2003, Vienna, Austria.
Tumour necrosis factor-a A2 polymorphism; a predisposing factor to non-ischaemic myocardial dysfunction? Densem CG, Yonan N, Hutchinson IV, Brooks NH. European Congress of Cardiology, September 2001
Haptoglobin polymorphism influences the development of cardiac transplant vasculopathy. Densem CG, Wassel J, Brooks NH, Yonan N, Keevil B. International Society for Heart and Lung Transplantation, April 2001
Tumour necrosis factor-a A2 polymorphism; a predisposing factor to non-ischaemic myocardial dysfunction? Densem CG, Yonan N, Hutchinson IV, Brooks NH. International Society for Heart and Lung Transplantation, April 2001
TGF-beta polymorphism influences the requirement for cyclosporine following cardiac transplantation. Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. American Heart Association, November, 2000
Significance of TGF Beta polymorphism and cardiac transplant vasculopathy. Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. European Society of Cardiology, August, 2000
Effect of tumour necrosis factor polymorphism on cardiac transplant vasculopathy. Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. European Society of Cardiology, August, 2000
Optimisation of angiotensin converting enzyme inhibitors in a specialist heart failure clinic. Densem CG, Burgess MI, Ray SG, Ward C. European Society of Cardiology, August, 2000
Significance of TGF beta polymorphism and cardiac transplant vasculopathy. Densem CG, Hutchinson IV Cooper A, Yonan N, Brooks NH. International Society for Heart and Lung Transplantation, April 2000
A Low producing TGF-b allele in the donor or recipient genotype protects from cardiac transplant vasculopathy. Densem CG, Hutchinson IV, Yonan N, Sheldon S, Brooks NH. International Society for Heart and Lung Transplantation, April 2000
Effect of interleukin-10 polymorphism on cardiac transplant vasculopathy. Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. International Society for Heart and Lung Transplantation, April 2000
Influence of interferon gamma polymorphism on cardiac transplant vasculopathy development. Densem CG, Hutchinson IV, Sheldon S, Yonan N, Brooks NH. International Society for Heart and Lung Transplantation, April 2000
Clinical significance of haptoglobin polymorphism on the development of cardiac transplant vasculopathy. Densem CG, Wassel J, Cooper A, Yonan N, Brooks NH, Keevil B. European Congress of Cardiology, August 1999
Protection from Cardiac Transplant Vasculopathy; TGF Beta Polymorphism. Densem CG, Hutchinson IV, Cooper A, Yonan N, Roberts T, Brooks NH. British Cardiac Society, May 1999
Haptoglobin phenotyping in heart transplant patients. Wassel J, Keevil BG, Densem CG. Proceedings of the ACB National Meeting, May 1999
TGF beta polymorphism does not influence the rise in creatinine following cardiac transplantation. Densem CG, Hutchinson IV, Fynn S, Yonan N, Brooks NH. International Society for Heart and Lung Transplantation, April 1999
Low producers of TGF beta are protected from cardiac transplant vasculopathy. Densem CG, Hutchinson IV, Cooper A, Roberts T, Yonan N, Brooks NH. International Society for Heart and Lung Transplantation, April 1999
Protection from Cardiac Transplant Vasculopathy; TGF Beta Polymorphism. Densem CG, Hutchinson IV, Cooper A, Yonan N, Roberts T, Brooks NH. British Transplantation Society 2nd Annual Congress, 30th March, 1999
|
